Bicuspid aortic valve: long-term morbidity and mortality

LI-TAN YANGYe, ZiZiYeWajih Ullah, MuhammadMuhammadWajih UllahMaleszewski, Joseph JJoseph JMaleszewskiScott, Christopher GChristopher GScottPadang, RatnasariRatnasariPadangPislaru, Sorin VSorin VPislaruNkomo, Vuyisile TVuyisile TNkomoMankad, Sunil VSunil VMankadPellikka, Patricia APatricia APellikkaOh, Jae KJae KOhRoger, Veronique LVeronique LRogerEnriquez-Sarano, MauriceMauriceEnriquez-SaranoMichelena, Hector IHector IMichelena2023-12-182023-12-182023-11-140195668Xhttps://www.scopus.com/record/display.uri?eid=2-s2.0-85176971836&doi=10.1093%2feurheartj%2fehad477&origin=inward&txGid=20817eff633fda04831f14d3bf931870https://scholars.lib.ntu.edu.tw/handle/123456789/637926Bicuspid aortic valve (BAV) is the most common congenital heart anomaly. Lifetime morbidity and whether long-term survival varies according to BAV patient-sub-groups are unknown. This study aimed to assess lifetime morbidity and long-term survival in BAV patients in the community.enBicuspid aortic valve; Community; Morbidity; Mortality[SDGs]SDG3Bicuspid aortic valve: long-term morbidity and mortalityjournal article10.1093/eurheartj/ehad477376110712-s2.0-85176971836